There is a revival of interest to the role of innate immunity in SLE and neutrophils as its main cellular components. Lupus neutrophils are characterized by impaired phagocytic capabilities, enhanced apoptosis and NETosis, an alternative mechanism ofneutrophil cell death, abnormal clearance ofapoptotic bodies and NETosis products. Therefore, investigation ofpathogenetic processes involving neutrophils is of immense importance, it may help in searching for potential therapeutic targets, understanding the mechanisms of drugs action already used in clinical practice and optimizing the therapeutic regimens by developing predictive factors. Free radical production is one of the crucial neutrophil functions. Thus, the study of neutrophil radical-producing function as a component of their functional status seems expedient. To attain this objective, a new method of luminol-enhanced chemiluminescence with a preliminary two-step stimulation by phorbol-12-myristate-13 acetate and formyl-methionyl-leucyl-phenylalanine was developed. Neutrophil radical-producing activity was evaluated in 46 SLE patients compared to 87 healthy controls. Increased spontaneous production of reactive oxygen species and more pronounced response to the PMA and fMLP effects were found. It was shown by higher specific peak and specific integral neutrophil activity, comparing to the control group. Interleukin-lfi for SLE patients’ neutrophils appeared to be both a pronounced stimulus and a priming agent, it was only a weak priming agent in healthy controls. These results are consistent with research data showing increased functional activity of neutrophils in SLE associated with increased production of pro-inflammatory cytokines, as well as increased production of neutrophil extracellular traps in the absence of additional stimulation, which may be a consequence of cytokine-primed condition.